This retrospective study in Ontario, Canada found that the perinatal and one-year postpartum suicide rate was comparable to international estimates.
This article presents ways to address the challenges of implementing collaborative care in low- and middle-income countries using experiences from three large-scale implementations in India and Nepal.
The Generalized Anxiety Disorder subscale of the Patient Health Questionnaire (GAD-7) is a quick and easy tool to help identify patients with anxiety and monitor treatment response.
Collaborative care is beneficial to primary care providers and their patients because it offers access to experts, the collaboration of a team, and improved behavioral health care.
A literature review, led by John Fortney, PhD, examined theoretical and empirical support for measurement-based care (MBC) and found that MBC is at a tipping point in the mental health care field.
The video, "A Tipping Point for Measurement-Based Care," created by the University of Washington Department of Psychiatry and Behavioral Sciences, summarizes this literature review.
This observational study found that antipsychotic prescribing fell significatly across Washington State following the implementation of child and adolescent psychiatry consultation services.
"A Tipping Point for Measurement-Based Care" is a video created by the University of Washington Department of Psychiatry and Behavioral Sciences. This video summarizes the findings of Dr. John Fortney's literature review that examined theoretical and empirical support for measurement-based care.
It is important to consider all the ways in which delivering effective, measurement-based integrated behavioral health treatment will add value to your organization. This resource can help you think about common domains of integrated care as you plan to launch your model of care.
These guidelines will help care managers working in a care team approximate the size of their caseload based on the complexity of the clinic's population.
The Patient Health Questionnaire 2 (PHQ-2) is used by some clinicians and organizations to screen patients for undiagnosed depression.